(NYSEMKT: INFU) Infusystem Holdings's forecast annual revenue growth rate of 3.89% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.43%.
Infusystem Holdings's revenue in 2026 is $143,335,000.On average, 6 Wall Street analysts forecast INFU's revenue for 2026 to be $2,952,323,740, with the lowest INFU revenue forecast at $2,822,463,720, and the highest INFU revenue forecast at $3,049,121,239. On average, 7 Wall Street analysts forecast INFU's revenue for 2027 to be $3,163,844,202, with the lowest INFU revenue forecast at $3,000,124,974, and the highest INFU revenue forecast at $3,356,642,514.
In 2027, INFU is forecast to generate $3,161,254,968 in revenue, with the lowest revenue forecast at $2,978,614,419 and the highest revenue forecast at $3,348,277,298.